Shanghai Jiahui International Hospital

Clinical Evaluation

Why this department is included

The official hematology service lists CAR-T for multiple myeloma, autologous stem-cell transplantation, bone-marrow testing, flow cytometry, and molecular testing. Official reports document international multiple-myeloma CAR-T cases.

This record supports research and hospital comparison. It does not determine individual eligibility or recommend treatment.

International access

A public institutional source documents an international-patient route for this hospital.

Pre-arrival clinical review

Documented through a published patient case. This is not a standing promise that every overseas case will receive remote review.

Treatment-specific acceptance

A treatment-specific international case is documented, but current criteria and capacity require direct confirmation.

Secure record channel

No hospital-approved secure medical-record submission channel is published in the reviewed sources.

Current CAR-T product

Current product availability is not published and must be confirmed with the clinical team.

Written public estimate

No complete written international-patient estimate is published in the reviewed sources.

This is a generic pathway-readiness checklist, not a hospital-issued submission checklist. Do not email medical records until the hospital confirms an approved submission channel.

1. 01Diagnosis, subtype, disease stage, and current disease status
2. 02Bone-marrow morphology, flow cytometry, cytogenetics, molecular testing, and recent response assessment
3. 03All prior treatment regimens, dates, responses, progression, and reasons for discontinuation
4. 04Recent PET-CT, CT, or MRI reports and original DICOM files when available
5. 05Recent blood counts, liver, kidney, coagulation, cardiac, and pulmonary assessments
6. 06Current infection status and relevant infectious-disease screening
7. 07Previous transplant, intensive-care admission, serious infection, and major treatment-toxicity records
8. 08Current medications, transfusion dependence, performance status, and home-country hematology support

Pre-Travel Hospital Intake Checklist

Key clinical and logistical points to coordinate directly with the hospital international patient center prior to admission:

• The currently available BCMA CAR-T product at each hospital
• Hospital-specific inclusion and exclusion criteria
• The hospital-approved secure medical-record submission channel
• Required document format and translation rules
• Manufacturing and expected waiting time
• Bridging-treatment availability
• Itemized international-patient estimate
• Minimum local monitoring period before return travel
• Formal shared-care protocol with the home-country hematology team

Sources used for this profile